Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis
Metabolic syndrome is associated with lower response rates with the initiation of an advanced therapy in RA, with similar effects for both TNFi and non-TNFi agents. Adipokines were strongly associated with metabolic syndrome but were not associated with clinical response.
Authors
- Jeffrey R. Curtis (ORCID: https://orcid.org/0000-0002-8907-8976)
- Joel M. Kremer (ORCID: https://orcid.org/0000-0001-6674-9901)
- Christina Charles‐Schoeman (ORCID: https://orcid.org/0000-0002-1768-7019)
- Joshua F. Baker (ORCID: https://orcid.org/0000-0003-0799-7563)
- Geoffrey M. Thiele (ORCID: https://orcid.org/0000-0001-5688-8596)
- Dimitrios A. Pappas (ORCID: https://orcid.org/0000-0001-8338-027X)
- Mónica Gumá (ORCID: https://orcid.org/0000-0003-1951-9411)
- Leslie R. Harrold (ORCID: https://orcid.org/0000-0002-0170-2747)
- Ted R. Mikuls (ORCID: https://orcid.org/0000-0002-0897-2272)
- George Reed
Institutions
- University of California, Los Angeles (US)
- University of Massachusetts Chan Medical School (US)
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- Research Foundation of The City University of New York (US)
- Philadelphia VA Medical Center (US)
- VA Nebraska Western Iowa Health Care System (US)
- University of Nebraska Medical Center (US)
- Albany Medical Center Hospital (US)
- Columbia University (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1002/art.43034
- Citations
- 8
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Institute of General Medical Sciences